Replies to post #3253 on Statera BioPharma Inc (STAB)

[ssc]

No need to listen to anything I say. Everything anyone needs to know is in the company's financials and other filings. If reverse split, increase in authorized shares, possible Nasdaq delisting, and more offerings at lower and lower prices sounds like reasons to buy, have at it.

[Herold]

The bottom line is the drug will work for crohn's disease with no side effects. However, they have no money to do the Phase 3 trials. Not sure how far 5.7 million will get them. They will probably continue to need to raise more so further dilution will occur. This is a long term play but how it all works out no one knows for sure.